Drug Approvals
🇺🇸 FDA Page 29FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 337–348 of 665 articles
The Future of Men's Health: A Federal Office on the Horizon
Ibrance Heirs and Gilead's Tubulis Data at ASCO26
Senators Grill NIH Director: Key Insights for Pharma
#ASCO26 Insights: Head and Neck Cancer Developments
Aptar Pharma Advances FDA-Funded Research Contract for Drug Approvals
First RAS Inhibitor Extends Survival in Metastatic Pancreatic Cancer
Mass General Brigham's Life-Saving Claims: A Closer Look
Best Cancer Stocks for 2026: Investment Insights
FDA in Flux: May 2026 Drug Approvals Update
FDA's Guidance on Animal Testing Alternatives: Industry Concerns
#ASCO26: Insights on VEGF Bispecifics from BioNTech-BMS and Pfizer-3SBio
FDA Fast Track Designation for Oncology Drugs: April 2026 Insights